Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
LAML | rs1037470 | chr2:3215593 | C/T | 5.94E-5 | 111 | 0 | 14.7 | 15.2 | KM Plot |
LAML | rs1037471 | chr2:3215503 | C/T | 5.94E-5 | 111 | 0 | 14.7 | 15.2 | KM Plot |
LAML | rs10401289 | chr19:12562702 | T/C | 1.05E-5 | 111 | 6.63 | 21.82 | 13.1 | KM Plot |
LAML | rs10402252 | chr19:12541547 | T/G | 1.87E-5 | 111 | 6.13 | 22.37 | 13.1 | KM Plot |
LAML | rs10402957 | chr19:48254392 | C/T | 8.06E-7 | 111 | 19.23 | 16.23 | 5.1 | KM Plot |
LAML | rs10404972 | chr19:12576573 | G/A | 8.24E-5 | 110 | 6.13 | 22.83 | 13.1 | KM Plot |
LAML | rs10405135 | chr19:48258578 | A/G | 3.21E-7 | 108 | 5.1 | 21.87 | 15.17 | KM Plot |
LAML | rs10406102 | chr19:12577008 | G/A | 9.09E-6 | 110 | 5.62 | 22.37 | 13.1 | KM Plot |
LAML | rs10406879 | chr19:48258551 | T/C | 3.21E-7 | 108 | 5.1 | 21.87 | 15.17 | KM Plot |
LAML | rs10411049 | chr19:12561240 | G/A | 1.05E-5 | 111 | 6.63 | 21.82 | 13.1 | KM Plot |
LAML | rs10411681 | chr19:48243509 | A/G | 1.16E-5 | 107 | 5.62 | 21.87 | 15.17 | KM Plot |
LAML | rs10411792 | chr19:12553144 | G/A | 1.05E-5 | 111 | 6.63 | 21.82 | 13.1 | KM Plot |
LAML | rs10413804 | chr19:12534105 | C/T | 4.1E-6 | 110 | 5.62 | 22.37 | 13.1 | KM Plot |
LAML | rs10414453 | chr19:12555547 | T/C | 1.05E-5 | 111 | 6.63 | 21.82 | 13.1 | KM Plot |
LAML | rs10420521 | chr19:12562511 | C/T | 2.35E-6 | 111 | 6.13 | 22.37 | 13.1 | KM Plot |